Pharmacokinetics and Pharmacodynamics

PKP-012

METHOTREXATE LEVELS IN CEREBROSPINAL FLUID IN CHILDREN TREATED WITH HIGH-DOSE METHOTREXATE

PKP-018

COMPARISON BETWEEN ASSAYS ON THE THERAPEUTIC DRUG MONITORIN OF EVEROLIMUS

PKP-019

EXPERIENCE OF ONCE DAILY TACROLIMUS INDIVIDUALISED DOSING THROUGH A BAYESIAN APPROACH IN THE NOVO LIVER TRANSPLANT RECIPIENTS

PKP-017

DOXORUBICIN PLASMA DETERMINATION BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

PKP-015

REVIEW OF SAFETY OUTCOMES OF MULTIPLE DAILY DOSIN OF AMIKACIN IN PAEDIATRIC FEBRILE NEUTROPENIC PATIENTS WITH CANCER

PKP-010

LEVETIRACETAM CLINICAL PHARMACOKINETICS IN ELDERLY PATIENTS WITH EPILEPSY

PKP-009

RELATION BETWEEN CLINICAL REMISSION AND TROUGH INFLIXIMAB LEVELS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

PKP-008

IMPLEMENTATION OF A MONITORING PROTOCOL FOR DIGOXIN

PKP-007

DPYD SNPs AND DISEASEE FREE SURVIVAL AFTER CAPECITABINE-BASED ADJUVANT TREATMENT

PKP-006

PHARMACIST’S ROLE IN CLINICAL PHARMACOKINETIC MONITORING OF DIGOXIN: MINIMISING TOXIC EFFECTS

PKP-005

DETERMINATION OF GENETIC POLYMORPHISMS AFFECTING METABOLISM OF THIOPURINES

PKP-044

GENETIC POLYMORPHISMS ASSOCIATED WITH COLORECTAL CANCER RISK

PKP-003

INFLUENCE OF CYTARABINE METABOLIC PATHWAY POLYMORPHISMS IN EFFECTIVENESS OF ACUTE MYELOID LEUKAEMIA INDUCTION TREATMENT

PKP-002

CONTINUOUS INFUSION VANCOMYCIN, A CASE REPORT

PKP-001

VANCOMYCIN INTRAPERITONEAL IN PEDIATRIC PATIENTS: NEED TO MONITOR PLASMA LEVELS

Pages